In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates.
about
Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model.Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumanniiVersatility of aminoglycosides and prospects for their future.Potency of parenteral antimicrobials including ceftolozane/tazobactam against nosocomial respiratory tract pathogens: considerations for empiric and directed therapy.In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains.
P2860
In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates.
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
In vitro synergistic activitie ...... am-negative clinical isolates.
@ast
In vitro synergistic activitie ...... am-negative clinical isolates.
@en
type
label
In vitro synergistic activitie ...... am-negative clinical isolates.
@ast
In vitro synergistic activitie ...... am-negative clinical isolates.
@en
prefLabel
In vitro synergistic activitie ...... am-negative clinical isolates.
@ast
In vitro synergistic activitie ...... am-negative clinical isolates.
@en
P2093
P2860
P1476
In vitro synergistic activitie ...... am-negative clinical isolates.
@en
P2093
Banevicius MA
Nicolau DP
Nightingale CH
Owens RC Jr
Quintiliani R
P2860
P304
P407
P577
1997-11-01T00:00:00Z